HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension.

Abstract
FMRFamide, a cardioexcitatory neuropeptide, directly activates a newly cloned amiloride-sensitive sodium channel that is expressed specifically in the brain and blocked by benzamil hydrochloride. In the present study, we investigated the effects of short- and long-term intracerebroventricular infusion of FMRFamide on arterial pressure, sympathetic activity, vasopressin release, and brain renin-angiotensin system genes in rats and studied the role of FMRFamide-activated brain sodium channels in salt-sensitive hypertension. The intracerebroventricular preinjection of FMRFamide and subsequent intracerebroventricular infusion of 0.15 mol/L NaCl increased mean arterial pressure (FMRFamide: 30 nmol/kg +13+/-2.6 mm Hg, P<0.01; 100 nmol/kg +21+/-1.8 mm Hg, P<0.01), heart rate, abdominal sympathetic activity, and plasma vasopressin concentration compared with vehicle. The intracerebroventricular copreinjection with either benzamil or CV-11974 abolished these increases. In rats administered a high-salt diet (8% NaCl), the continuous intracerebroventricular infusion of FMRFamide (50 and 200 nmol. kg(-1). d(-1)) for 5 days increased mean arterial pressure, heart rate, urinary excretion of vasopressin and norepinephrine, and mRNAs of renin, angiotensin I-converting enzyme, and angiotensin II type 1 receptor in hypothalamus and brain stem compared with vehicle. These increases were abolished by intracerebroventricular coinfusion of benzamil. In rats administered a low-salt diet (0.3% NaCl), however, increases in these variables were smaller than those in rats receiving a high-salt diet. Together, these findings suggest that brain FMRFamide-activated sodium channels may be involved in the mechanism of salt-sensitive hypertension through regulation of the brain renin-angiotensin system.
AuthorsM Nishimura, K Ohtsuka, H Takahashi, M Yoshimura
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 35 Issue 1 Pt 2 Pg. 443-50 (Jan 2000) ISSN: 0194-911X [Print] United States
PMID10642339 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • RNA, Messenger
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin
  • Sodium Channels
  • Sodium Chloride, Dietary
  • benzamil
  • Arginine Vasopressin
  • FMRFamide
  • Amiloride
  • Peptidyl-Dipeptidase A
  • Renin
  • Norepinephrine
Topics
  • Amiloride (analogs & derivatives, pharmacology)
  • Anesthesia
  • Animals
  • Arginine Vasopressin (blood, urine)
  • Blood Pressure (drug effects)
  • Brain Chemistry (drug effects, genetics)
  • DNA Primers
  • FMRFamide (pharmacology, urine)
  • Ganglia, Sympathetic (chemistry, drug effects, enzymology)
  • Gene Expression (drug effects)
  • Heart Rate (drug effects)
  • Hypertension (physiopathology)
  • Injections, Intraventricular
  • Male
  • Norepinephrine (urine)
  • Peptidyl-Dipeptidase A (genetics)
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Wistar
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin (genetics)
  • Renin (genetics)
  • Renin-Angiotensin System (physiology)
  • Sodium Channels (physiology)
  • Sodium Chloride, Dietary (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: